"Medical Clinic - Integrative Medicine, Endocrinologist"

During the past decade, Martha Gomez Cuellar M.D. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Martha Gomez Cuellar M.D." #1 collaborator was "Insulet Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Martha Gomez Cuellar M.D." are "Type 1 Diabetes Mellitus" (2 trials), "Type 2 Diabetes" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Diabetes" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Martha Gomez Cuellar M.D." in a lesser frequency.

Most popular intervention types in "Martha Gomez Cuellar M.D." are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Degludec" (5 trials), "Insulin Efsitora Alfa" (2 trials), "LY3209590" (2 trials), "Tirzepatide" (2 trials) and "Human regular U-500 insulin (CSII)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Martha Gomez Cuellar M.D." are 8 trials for "All" genders.

Currently, there are NaN active trials in "Martha Gomez Cuellar M.D.". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Martha Gomez Cuellar M.D., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Martha Gomez Cuellar M.D., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".